Yumanity Therapeutics is transforming drug discovery for neurodegenerative diseases caused by protein misfolding." title="" class="btn" data-container="body" data-html="true" data-id="284958" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#b3d4fc" tabindex="0" data-original-title="Yumanity"> 920 3,703 3,703
Activities
Entity types
Location
Seattle, WA, USA
Seattle
United States of America
Employees
Scale: 11-50
Estimated: 41
Engaged corporates
7Added in Motherbase
1 year, 11 months ago
Developing next-generation immunotherapies for cancer patients!
Kineta is a clinical stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients’ lives.
Antivirals, Chronic Pain, Immuno-oncology, Biodefense, Immunology, Virology, Lassa fever, and Neuroscience
Kineta fills a void in the biopharmaceutical industry by efficiently advancing first-in-class novel immunotherapies from discovery to proof of concept.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
![]() | Biotechnology Innovation Organization | Other 29 Sep 2023 | | |
![]() Financial Times Media, Newspaper Publishing | Financial Times Media, Newspaper Publishing | Other 27 Nov 2017 | | |
![]() Amgen Biotechnology, Biotechnology Research | Amgen Biotechnology, Biotechnology Research | Other 28 Aug 2018 | | |
![]() Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Other 5 Jun 2019 | | |
![]() MSD Pharmaceutical, Pharmaceutical Manufacturing | MSD Pharmaceutical, Pharmaceutical Manufacturing | Other 11 Jan 2022 | | |
![]() Nasdaq Finance, Financial Services | Nasdaq Finance, Financial Services | Other 23 Dec 2020 27 Jul 2023 | | |
![]() Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Other 26 Oct 2021 | |